HB 425

  • Delaware House Bill
  • 151st General Assembly (2021-2022)
  • Introduced in House Jun 14, 2022
  • Passed House Jun 14, 2022
  • Passed Senate Jun 30, 2022
  • Signed by Governor Oct 21, 2022

An Act To Amend Title 16 Of The Delaware Code Relating To The Lyme Disease Oversight Board.

Abstract

This bill makes needed changes to the Lyme Disease Oversight Board by adding 2 members including an infectious disease epidemiologist and a licensed veterinarian or entomology specialist.

Bill Sponsors (29)

Votes


Jun 30, 2022

Jun 14, 2022

Actions


Oct 21, 2022

Office of the Governor

Signed by Governor

Jun 30, 2022

Senate

Passed By Senate. Votes: 21 YES

Jun 21, 2022

Senate

Reported Out of Committee (Legislative Oversight & Sunset) in Senate with 3 Favorable, 2 On Its Merits

  • Committee-Passage
  • Committee-Passage-Favorable
Legislative Oversight & Sunset

Jun 14, 2022

House

Amendment HA 2 to HB 425 - Stricken in House

House

Amendment HA 1 to HB 425 - Stricken in House

House

Amendment HA 3 to HB 425 - Passed In House by Voice Vote

House

Passed By House. Votes: 40 YES 1 ABSENT

Senate

Assigned to Legislative Oversight & Sunset Committee in Senate

  • Introduction
  • Referral-Committee
Legislative Oversight & Sunset

Jun 13, 2022

House

Amendment HA 3 to HB 425 - Introduced and Placed With Bill

May 18, 2022

House

Reported Out of Committee (Administration) in House with 4 On Its Merits

  • Committee-Passage
Administration

May 17, 2022

House

Amendment HA 2 to HB 425 - Introduced and Placed With Bill

House

Amendment HA 1 to HB 425 - Introduced and Placed With Bill

May 12, 2022

House

Introduced and Assigned to Administration Committee in House

  • Introduction
  • Referral-Committee
Administration

Bill Text

Bill Text Versions Format
Bill Text PDF HTML
HA 3 to HB 425 HTML PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Delaware General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.